{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:51:14Z","timestamp":1780091474762,"version":"3.54.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T00:00:00Z","timestamp":1592697600000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jpeds.2019.03.032","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T08:41:57Z","timestamp":1556613717000},"page":"161-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Intermediate-Term Efficacy and Tolerance of Statins in Children"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4577-9930","authenticated-orcid":false,"given":"Nathalie","family":"Mamann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lemale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Dubern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Girardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2138-6702","authenticated-orcid":false,"given":"Patrick","family":"Tounian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2019.03.032_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpeds.2015.11.019","article-title":"Prevalence of familial hypercholesterolemia in adolescents: potential value of universal screening?","volume":"170","author":"Pang","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.03.032_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmedgenet-2014-102405","article-title":"Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR\/APOB\/PCSK9 mutations","volume":"51","author":"Futema","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.jpeds.2019.03.032_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.atherosclerosis.2009.07.034","article-title":"Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth","volume":"208","author":"Morrison","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jpeds.2019.03.032_bib4","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/01.ATV.20.9.2070","article-title":"Arterial mechanical changes in children with familial hypercholesterolemia","volume":"20","author":"Aggoun","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jpeds.2019.03.032_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","article-title":"Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia","volume":"363","author":"Wiegman","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jpeds.2019.03.032_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","article-title":"Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia","volume":"49","author":"Stone","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2019.03.032_bib7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.107.181946","volume":"115","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2019.03.032_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jama.2016.6176","article-title":"Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: evidence report and systematic review for the US Preventive Services Task Force","volume":"316","author":"Lozano","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2019.03.032_bib9","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jpeds.2019.03.032_bib10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa065994","article-title":"Long-term follow-up of the West of Scotland Coronary Prevention Study","volume":"357","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2019.03.032_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.106.671016","article-title":"Statin treatment in children with familial hypercholesterolemia: the younger, the better","volume":"116","author":"Rodenburg","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2019.03.032_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2019.03.032_bib13","first-page":"CD006401","article-title":"Statins for children with familial hypercholesterolemia","volume":"7","author":"Vuorio","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2019.03.032_bib14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/bmj.3.5826.566","article-title":"Classification and definition of protein-calorie malnutrition","volume":"3","author":"Waterlow","year":"1972","journal-title":"Br Med J"},{"key":"10.1016\/j.jpeds.2019.03.032_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40272-014-0116-y","article-title":"Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence","volume":"17","author":"Braamskamp","year":"2015","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.jpeds.2019.03.032_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpeds.2017.02.047","article-title":"Statin-associated myopathy in a pediatric preventive cardiology practice","volume":"185","author":"Johnson","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.03.032_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/11591650-000000000-00000","article-title":"Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability","volume":"13","author":"Carreau","year":"2011","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jpeds.2019.03.032_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jpeds.2019.03.032_bib19","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-Associated Myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2019.03.032_bib20","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpeds.2019.03.032_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.arcped.2010.10.017","volume":"18","author":"Girardet","year":"2011","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jpeds.2019.03.032_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2019.03.032_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2006.09.030","article-title":"Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"195","author":"Arambepola","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jpeds.2019.03.032_bib24","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"issue":"Suppl 5","key":"10.1016\/j.jpeds.2019.03.032_bib25","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619303889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619303889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:00:17Z","timestamp":1758358817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347619303889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":25,"alternative-id":["S0022347619303889"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.03.032","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermediate-Term Efficacy and Tolerance of Statins in Children","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}